Literature DB >> 17134019

Comparison of 18F-fluoromethylcholine and 2-deoxy-D-glucose in the distribution of tumor and inflammation.

Kazuo Kubota1, Shozo Furumoto, Ren Iwata, Hiroshi Fukuda, Kazunori Kawamura, Kiichi Ishiwata.   

Abstract

PURPOSE: The distribution characteristics of 18F-fluoromethylcholine (18F-choline) in tumor and inflammatory tissue were compared with those of 14C or 3H-2-deoxyglucose (2DG) as a substitute for fluorodeoxyglucose (FDG).
METHODS: A solid tumor model of AH 109A in the back of Donryu rats and an aseptic inflammation model of turpentine oil injection subcutaneously in rats were used for experiments. Tissue distribution was examined at 5, 30 and 60 min after injection of a mixture of 18F-choline and 3H-2DG. Double-tracer high-resolution autoradiographs (ARGs) of tumor and inflammation were obtained using 18F-choline and 14C-2DG. Whole body (WB) ARG was performed with 18F-choline.
RESULTS: Tumor uptake of 18F-choline reached a peak at 30 min, when the tumor to blood ratio was 5.1. Both tumor and inflammation uptake of 2DG were higher than those of 18F-choline. 18F-choline uptake by inflammation was lower than that by tumor. The tumor to brain uptake ratio was 5.7 with 18F-choline and 1.2 with 2DG. In the ARG of inflammation, linear or ring-like structures of 2DG uptake were observed in the wall of the abscess, but were not identified with 18F-choline. Photomicrography showed that the uptake was limited to granulocytes, macrophages and fibroblasts, consistent with sub-acute or chronic inflammation.
CONCLUSION: 18F-choline uptake by inflammation was lower than that of 2DG in the tissue distribution study, and 18F-choline uptake by abscess wall was significantly lower than that of 2DG in the autoradiography study. Our results may suggest the feasibility of 18F-choline-PET imaging for the differential diagnosis of cancer and chronic inflammation in lung and brain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17134019     DOI: 10.1007/bf03026816

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  10 in total

1.  Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research.

Authors:  John Kurhanewicz; Daniel B Vigneron; Kevin Brindle; Eduard Y Chekmenev; Arnaud Comment; Charles H Cunningham; Ralph J Deberardinis; Gary G Green; Martin O Leach; Sunder S Rajan; Rahim R Rizi; Brian D Ross; Warren S Warren; Craig R Malloy
Journal:  Neoplasia       Date:  2011-02       Impact factor: 5.715

2.  PET imaging of inflammation and adenocarcinoma xenografts using vascular adhesion protein 1 targeting peptide 68Ga-DOTAVAP-P1: comparison with 18F-FDG.

Authors:  Anu Autio; Tiina Ujula; Pauliina Luoto; Satu Salomäki; Sirpa Jalkanen; Anne Roivainen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-06-04       Impact factor: 9.236

3.  Improved discrimination between benign and malignant LDCT screening-detected lung nodules with dynamic over static 18F-FDG PET as a function of injected dose.

Authors:  Qing Ye; Jing Wu; Yihuan Lu; Mika Naganawa; Jean-Dominique Gallezot; Tianyu Ma; Yaqiang Liu; Lynn Tanoue; Frank Detterbeck; Justin Blasberg; Ming-Kai Chen; Michael Casey; Richard E Carson; Chi Liu
Journal:  Phys Med Biol       Date:  2018-09-06       Impact factor: 3.609

4.  Thyroid 18F-fluorocholine uptake in patients with chronic autoimmune thyroiditis.

Authors:  Renaud Ciappuccini; Virginie Saguet-Rysanek; Marine Dorbeau; Justine Lequesne; Camille Linard; Sophie Lefevre-Arbogast; Bénédicte Clarisse; Stéphane Bardet
Journal:  Eur Thyroid J       Date:  2022-06-21

Review 5.  Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies.

Authors:  Liem Minh Phan; Sai-Ching Jim Yeung; Mong-Hong Lee
Journal:  Cancer Biol Med       Date:  2014-03       Impact factor: 4.248

6.  Correlation of Glut-1 and Glut-3 expression with F-18 FDG uptake in pulmonary inflammatory lesions.

Authors:  Zhen Guang Wang; Ming Ming Yu; Yu Han; Feng Yu Wu; Guang Jie Yang; Da Cheng Li; Si Min Liu
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

7.  Investigation of Association Between Borderline Pancreatic Head Cancer and Glucose Uptake by Using Positron-Emission Tomographic Studies.

Authors:  Ying Zhang; Lei Qin; Changming Zhang
Journal:  Med Sci Monit       Date:  2017-10-16

8.  Is C-11 Methionine PET an alternative to 18-F FDG-PET for identifying recurrent laryngeal cancer after radiotherapy?

Authors:  Jan Wedman; Jan Pruim; Lisa van der Putten; Otto S Hoekstra; Remco de Bree; Boukje A C van Dijk; Bernard F A M van der Laan
Journal:  Clin Otolaryngol       Date:  2018-11-18       Impact factor: 2.597

9.  Fluorodeoxyglucose and C-Choline positron emission tomography for distinction of metastatic plexopathy and neuritis: a case report.

Authors:  Anna L Bartels; Clark J Zeebregts; Roelien H Enting; Riemer Hja Slart
Journal:  Cases J       Date:  2009-12-15

10.  A comparative uptake study of multiplexed PET tracers in mice with turpentine-induced inflammation.

Authors:  Tingting Huang; Hongliang Wang; Ganghua Tang; Xiang Liang; Dahong Nie; Chang Yi; Kening Wu
Journal:  Molecules       Date:  2012-11-26       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.